What is the fair value of Hypera SA ADR (OTC-HYPM.Y) stock?

The current fair value estimate for Hypera SA ADR (OTC-HYPM.Y) is $6.74. This implies an estimated upside of 41.0% versus the current market price.

Is Hypera SA ADR (OTC-HYPM.Y) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 41.0% versus the current market price.

How is the financial health of Hypera SA ADR?

The current financial health read for Hypera SA ADR (OTC-HYPM.Y) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Hypera SA ADR's next earnings date?

The next earnings date currently listed for Hypera SA ADR (OTC-HYPM.Y) is October 27, 2026.

Does Hypera SA ADR (OTC-HYPM.Y) pay dividends?

Based on the current data, dividend yield is 3.9%.

What is the P/E ratio for Hypera SA ADR (OTC-HYPM.Y)?

The current P/E ratio listed for Hypera SA ADR (OTC-HYPM.Y) is 9.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Hypera SA ADR?

The current market capitalization listed for Hypera SA ADR is 3.448 B.

What is the enterprise value of Hypera SA ADR?

The current enterprise value listed for Hypera SA ADR is 4.467 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Hypera SA ADR?

The ticker symbol for Hypera SA ADR is OTC-HYPM.Y, and the stock is listed on OTC Markets.

Where is Hypera SA ADR (OTC-HYPM.Y) listed?

Hypera SA ADR (OTC-HYPM.Y) is listed on OTC Markets.

What is the debt-to-total-capital ratio for Hypera SA ADR?

The current debt-to-total-capital ratio listed for Hypera SA ADR is 31.2%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Hypera SA ADR?

The free float listed for Hypera SA ADR is 43.4%. Free float helps investors understand how much of the share base is available for public trading.

Hypera SA ADR (HYPMY) Fair Value & Stock Analysis

Hypera SA ADR (HYPMY)

Hypera S.A. ADR is a depositary receipt representing common stock of Hypera S.A., a Brazilian pharmaceutical company listed on OTC Markets. Through its operations in Brazil, the company markets a broad portfolio of healthcare products, including sweeteners, analgesics and anti-inflammatories, cold and flu remedies, decongestants, antihistamines, antiseptics, herbal medicines, gastrointestinal products, generics, skincare items, supplements, vitamins, and other consumer health brands. Its products are sold under brands such as Adocyl, Doril, Buscopan, Neosaldina, neo quimica, and Addera. Founded in 1999 and headquartered in São Paulo, Brazil, the company was previously known as Hypermarcas S.A. before adopting the Hypera S.A. name in February 2018.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
OTC-HYPM.Y	$6.74	41.0% Upside	Undervalued	Not available	Not available	Great	3.9%	October 27, 2026	9.7x	1.2x	1.9x	3.448 B	4.467 B	31.2%	43.4%	7.9	42.9%	145.1%